C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2006
11/23/2006	CA2608770A1 Improved nanobodies against tumor necrosis factor-alpha
11/23/2006	CA2608498A1 Anti-gm-csf antibodies and uses therefor
11/23/2006	CA2608473A1 Combination therapy
11/23/2006	CA2607663A1 Compositions and methods for increasing the stability of antibodies
11/23/2006	CA2607305A1 Anti-mesothelin antibodies useful for immunological assays
11/23/2006	CA2607291A1 Compositions and methods for modulating immune responses
11/23/2006	CA2606867A1 Methods of using pnkp30, a member of the b7 family, to modulate the immune system
11/23/2006	CA2606576A1 High-level expression of recombinant antibody in a mammalian host cell
11/22/2006	EP1724352A2 Specific nucleic acids and polypeptide from pathogenic strains of Neisseria
11/22/2006	EP1724351A2 Human Kallikrein-like genes
11/22/2006	EP1724349A1 TIE Ligand Homologues
11/22/2006	EP1724286A1 Variant CD44 polypeptide, polynucleotides encoding same, antibodies directed there against and method of using same for diagnosing and treating inflammatory diseases
11/22/2006	EP1724285A1 Anti-HBs monoclonal antibodies
11/22/2006	EP1724284A2 GLP-1 fusion proteins
11/22/2006	EP1724283A2 Corticotropin releasing factor receptor 2 agonists
11/22/2006	EP1724282A2 Method for the production of non-immunogenic proteins
11/22/2006	EP1723970A1 Medicinal composition containing cxcr3 inhibitor
11/22/2006	EP1723967A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
11/22/2006	EP1723964A1 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
11/22/2006	EP1723430A2 Method for detecting the activatable free form of psa and the use thereof for diagnosing benign pathologies of the prostate and adenocarcinoma of the prostate
11/22/2006	EP1723418A2 Binding agents
11/22/2006	EP1723179A1 Anti fk778 antibodies and high sensitive immunoassay methods
11/22/2006	EP1723178A2 Human g-protein chemokine receptor (ccr5) hdgnr10
11/22/2006	EP1723174A1 A novel modulator of glucocorticoid receptor activities
11/22/2006	EP1723169A1 Novel tat complexes, and vaccines comprising them
11/22/2006	EP1723167A1 Novel phosphorylated sequences of phosphatase cdc25b, antibodies directed against said sequences and use thereof
11/22/2006	EP1722765A2 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone
11/22/2006	EP1511770B1 Glycoprotein vi-fc fusion protein for the treatment of vascular diseases
11/22/2006	EP1370575B1 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
11/22/2006	EP1282444B1 Antithrombotic agents
11/22/2006	EP1266025B1 Protein scaffolds for antibody mimics and other binding proteins
11/22/2006	EP1173465B1 Novel human voltage-gated potassium channel
11/22/2006	EP1163522B1 Method for detecting msrv-1 induced superantigen activity in a biological sample
11/22/2006	EP1146899B1 Methods of using neurotrophin 3 (nt-3) for the treatment of gastrointestinal hypomotility disorders
11/22/2006	EP1071774B1 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof
11/22/2006	EP1053309B1 Compositions and methods for wound healing
11/22/2006	EP1000158B1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
11/22/2006	EP0999273B1 HUMAN GENE RecQ4 ENCODING HELICASE
11/22/2006	EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase
11/22/2006	EP0825996B1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/22/2006	EP0574461B2 High affinity humanized monoclonal antibodies
11/22/2006	CN1867667A Coronavirus, nucleic acid, protein and methods for the generation of vaccine, medicaments and diagnostics
11/22/2006	CN1867588A Product comprising a c4bp core protein and a monomeric antigen, and its use
11/22/2006	CN1867587A Anti-Lewis Y anti-idiotypic antibodies and uses thereof
11/22/2006	CN1867586A Multispecific deimmunized CD3-binders
11/22/2006	CN1867585A Fully human antibodies against human 4-1BB (CD137)
11/22/2006	CN1867584A Native immunoglobulin binding reagents and methods for making and using same
11/22/2006	CN1867583A Optimized Fc variants and methods for their generation
11/22/2006	CN1865285A Specific anti-human liver cancer phage single-chain antibody HscFv4-16 gene and its uses
11/22/2006	CN1865284A Receptor of the edb-fibronectin domains
11/22/2006	CN1285608C Parainfluenza virus glycoproteins and vaccines
11/21/2006	US7138508 Inhibitor protein of the wnt signal pathway
11/21/2006	US7138504 Reagents and methods for mycophenolic acid immunoassay
11/21/2006	US7138503 Synthetic molecules that specifically react with target sequences
11/21/2006	US7138502 Peptide for use in the prevention and treatment of microorganismal infections
11/21/2006	US7138501 Antibodies that immunospecifically bind BLyS
11/21/2006	US7138499 antibody that binds to a peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily
11/21/2006	US7138498 DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of
11/21/2006	US7138497 Genetic engineering; crosslinking polypeptide on carrier
11/21/2006	US7138496 Antibody that binds to loop 6 of human CXCR4, especially a single chain antibody
11/21/2006	US7138494 Comprises amino acid transport protein (ASC-1) for regulating NMDA-type glutamic acid receptor; treatment of nervous system disorders; antiproliferative agents; gene expression inhibition
11/21/2006	US7138486 Insulinotropic hormone derivatives and uses thereof
11/21/2006	US7138371 Remodeling and glycoconjugation of peptides
11/21/2006	US7138370 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
11/21/2006	US7138252 For prevention/treatment of allergies/cancer/drug addiction/poisoning
11/21/2006	US7138244 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
11/21/2006	US7138243 NTB-A, a surface molecule involved in natural killer cells activity
11/21/2006	US7138241 Isolating preferential antibodies; obtain sample containing antibody, incubate with antigen, incubate with modulator of antibody binding, recover antibody
11/21/2006	US7138234 Gene involved in CADASIL, method of diagnosis and therapeutic application
11/21/2006	US7138228 Protein O-sulfonation
11/21/2006	US7138120 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
11/21/2006	US7138119 Compositions and methods for inhibition of HIV-1 infection
11/21/2006	US7138118 Methods of treating rheumatoid arthritis with anti-TNF antibodies
11/21/2006	US7138117 Antigen-binding fragment or antibody which binds to a mammalian CC-chemokine receptor 4 (CCR4); medical diagosis, therapy, or prophylaxis; antiinflammatory agents
11/21/2006	US7138116 Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
11/21/2006	US7138115 Administering monoclonal or polyclonal antibody to treat multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease
11/21/2006	US7138103 Completitive binding
11/21/2006	CA2433386C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r9
11/21/2006	CA2341143C Production of motif-specific and context-independent antibodies using peptide libraries as antigens
11/21/2006	CA2201153C Monoclonal antibody to human cardiac myoglobin
11/17/2006	CA2549902A1 Cd44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
11/16/2006	WO2006122257A2 Nebulization of monoclonal antibodies for treating pulmonary diseases
11/16/2006	WO2006122079A1 Il-31 monoclonal antibodies and methods of use
11/16/2006	WO2006122047A1 Cardiovascular disease therapies
11/16/2006	WO2006122046A2 Vascular disease therapies
11/16/2006	WO2006121422A2 Antibodies against clostridium difficile toxins and uses thereof
11/16/2006	WO2006121240A1 Acute leukemia and lymphoblastic lymphoma-specific cd43 epitope and use thereof
11/16/2006	WO2006121207A1 Methods for damaging cells using effector function of anti-dsc2 antibody
11/16/2006	WO2006121168A1 Human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
11/16/2006	WO2006121159A1 Humanized cdr-grafted antibody specifically reacting with cd10 and antibody fragment of the same
11/16/2006	WO2006121047A1 Method for determination of megsin in biological sample
11/16/2006	WO2006120575A2 Tcr-independent activation of t cells with co-lignation of cd28 and cd81
11/16/2006	WO2006120473A2 Mhc class i and ii peptide antigens derived from tumour antigen 5t4
11/16/2006	WO2006120455A2 Ovalbumin promoter constructs for retroviral vectors
11/16/2006	WO2006120434A1 Method of fetal cell enrichment
11/16/2006	WO2006120019A2 Mcm9, a member of the mcm2-8 family and its use in pharmaceutical compositions
11/16/2006	WO2006119983A2 Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
11/16/2006	WO2006119965A2 Growth factor mutants with altered biological attributes
11/16/2006	WO2006119560A1 Immunoglobulin fraction and process therefor
11/16/2006	WO2006104677A3 Antibodies that bind ov064 and methods of use therefor

1 ... 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 ... 1494